Testing effectiveness (Phase 2)Study completedNCT00446433
What this trial is testing
Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Who this might be right for
Crohn's Disease
Celgene Corporation 90